This FTSE 100 firm's smaller than rivals but could benefit from its big US manufacturing footprint and competitive market ...

But it wasn’t just exhaustion, there were also symptoms such as dizziness and tunnel vision that had doctors worried.“They ...

The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on June ...

Announced at Abu Dhabi Global Health Week, this initiative reinforces the emirate's commitment to create personalised impact ...

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

Glaxosmithkline Pharmaceuticals Ltd, Marico Ltd, Caplin Point Laboratories Ltd and Aarti Pharmalabs Ltd are among the other losers in the BSE's 'A' group today, 21 April 2025.